Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Reduced Sensory-Evoked Locus Coeruleus-Norepinephrine Neural Activity in Female Rats With a History of Dietary-Induced Binge Eating.

Bello NT, Yeh CY, James MH.

Front Psychol. 2019 Sep 4;10:1966. doi: 10.3389/fpsyg.2019.01966. eCollection 2019.

2.

Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil.

Mohammadkhani A, James MH, Pantazis CB, Aston-Jones G.

Brain Res. 2019 Sep 14:146461. doi: 10.1016/j.brainres.2019.146461. [Epub ahead of print]

PMID:
31526801
3.

The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand.

Pantazis CB, James MH, Bentzley BS, Aston-Jones G.

Addict Biol. 2019 Jul 11:e12795. doi: 10.1111/adb.12795. [Epub ahead of print]

PMID:
31297913
4.

The role of orexin-1 receptor signaling in demand for the opioid fentanyl.

Fragale JE, Pantazis CB, James MH, Aston-Jones G.

Neuropsychopharmacology. 2019 Sep;44(10):1690-1697. doi: 10.1038/s41386-019-0420-x. Epub 2019 May 21.

PMID:
31112988
5.

The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task.

Wiskerke J, James MH, Aston-Jones G.

Brain Res. 2019 Apr 16. pii: S0006-8993(19)30216-1. doi: 10.1016/j.brainres.2019.04.017. [Epub ahead of print]

PMID:
31002819
6.

Understanding low COPD exacerbation rates in Japan: a review and comparison with other countries.

Ishii T, Nishimura M, Akimoto A, James MH, Jones P.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 26;13:3459-3471. doi: 10.2147/COPD.S165187. eCollection 2018. Review.

7.

Activation of lateral hypothalamic group III metabotropic glutamate receptors suppresses cocaine-seeking following abstinence and normalizes drug-associated increases in excitatory drive to orexin/hypocretin cells.

Yeoh JW, James MH, Adams CD, Bains JS, Sakurai T, Aston-Jones G, Graham BA, Dayas CV.

Neuropharmacology. 2019 Aug;154:22-33. doi: 10.1016/j.neuropharm.2018.09.033. Epub 2018 Sep 22.

PMID:
30253175
8.

Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin/hypocretin-1 receptor antagonist in rats.

James MH, Bowrey HE, Stopper CM, Aston-Jones G.

Eur J Neurosci. 2019 Aug;50(3):2602-2612. doi: 10.1111/ejn.14166. Epub 2018 Oct 14.

PMID:
30240516
9.

Increased Number and Activity of a Lateral Subpopulation of Hypothalamic Orexin/Hypocretin Neurons Underlies the Expression of an Addicted State in Rats.

James MH, Stopper CM, Zimmer BA, Koll NE, Bowrey HE, Aston-Jones G.

Biol Psychiatry. 2019 Jun 1;85(11):925-935. doi: 10.1016/j.biopsych.2018.07.022. Epub 2018 Aug 7.

PMID:
30219208
10.

A randomized trial of symptom-based management in Japanese patients with COPD.

Betsuyaku T, Kato M, Fujimoto K, Kobayashi A, Hayamizu T, Hitosugi H, Hagan G, James MH, Jones PW.

Int J Chron Obstruct Pulmon Dis. 2018 Aug 13;13:2409-2423. doi: 10.2147/COPD.S152723. eCollection 2018.

11.
12.

Temporally specific miRNA expression patterns in the dorsal and ventral striatum of addiction-prone rats.

Quinn RK, James MH, Hawkins GE, Brown AL, Heathcote A, Smith DW, Cairns MJ, Dayas CV.

Addict Biol. 2018 Mar;23(2):631-642. doi: 10.1111/adb.12520. Epub 2017 Jun 13.

PMID:
28612502
13.

New directions for the treatment of depression: Targeting the photic regulation of arousal and mood (PRAM) pathway.

Bowrey HE, James MH, Aston-Jones G.

Depress Anxiety. 2017 Jul;34(7):588-595. doi: 10.1002/da.22635. Epub 2017 May 10. Review.

14.

Orexin/Hypocretin, Central Amygdala, and Escalation of Cocaine Intake.

James MH, Aston-Jones G.

Biol Psychiatry. 2017 Apr 1;81(7):552-553. doi: 10.1016/j.biopsych.2017.01.010. No abstract available.

15.

Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders.

James MH, Campbell EJ, Dayas CV.

Curr Top Behav Neurosci. 2017;33:197-219. doi: 10.1007/7854_2016_56. Review.

PMID:
28083790
16.

A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?

James MH, Mahler SV, Moorman DE, Aston-Jones G.

Curr Top Behav Neurosci. 2017;33:247-281. doi: 10.1007/7854_2016_57. Review.

17.

Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats.

Moorman DE, James MH, Kilroy EA, Aston-Jones G.

Brain Res. 2017 Jan 1;1654(Pt A):34-42. doi: 10.1016/j.brainres.2016.10.018. Epub 2016 Oct 19.

18.

The Ventral Pallidum: Proposed Integrator of Positive and Negative Factors in Cocaine Abuse.

James MH, Aston-Jones G.

Neuron. 2016 Oct 5;92(1):5-8. doi: 10.1016/j.neuron.2016.09.042.

19.

Prelimbic to Accumbens Core Pathway Is Recruited in a Dopamine-Dependent Manner to Drive Cued Reinstatement of Cocaine Seeking.

McGlinchey EM, James MH, Mahler SV, Pantazis C, Aston-Jones G.

J Neurosci. 2016 Aug 17;36(33):8700-11. doi: 10.1523/JNEUROSCI.1291-15.2016.

20.

Rapamycin reduces motivated responding for cocaine and alters GluA1 expression in the ventral but not dorsal striatum.

James MH, Quinn RK, Ong LK, Levi EM, Smith DW, Dickson PW, Dayas CV.

Eur J Pharmacol. 2016 Aug 5;784:147-54. doi: 10.1016/j.ejphar.2016.05.013. Epub 2016 May 12.

PMID:
27181066
21.

Orexin/hypocretin neuron activation is correlated with alcohol seeking and preference in a topographically specific manner.

Moorman DE, James MH, Kilroy EA, Aston-Jones G.

Eur J Neurosci. 2016 Mar;43(5):710-20. doi: 10.1111/ejn.13170. Epub 2016 Feb 16.

22.

Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials.

Gross AS, Goldfrad C, Hozawa S, James MH, Clifton CS, Sugiyama Y, Jacques L.

BMC Pulm Med. 2015 Dec 24;15:165. doi: 10.1186/s12890-015-0159-z.

23.

Commentary: "Prdm13 regulates subtype specification of retinal amacrine interneurons and modulates visual sensitivity".

Bowrey HE, James MH.

Front Cell Neurosci. 2015 Oct 27;9:424. doi: 10.3389/fncel.2015.00424. eCollection 2015. No abstract available.

24.

Differential roles of medial prefrontal subregions in the regulation of drug seeking.

Moorman DE, James MH, McGlinchey EM, Aston-Jones G.

Brain Res. 2015 Dec 2;1628(Pt A):130-46. doi: 10.1016/j.brainres.2014.12.024. Epub 2014 Dec 18. Review.

25.

Electrophysiological characteristics of paraventricular thalamic (PVT) neurons in response to cocaine and cocaine- and amphetamine-regulated transcript (CART).

Yeoh JW, James MH, Graham BA, Dayas CV.

Front Behav Neurosci. 2014 Aug 22;8:280. doi: 10.3389/fnbeh.2014.00280. eCollection 2014.

26.

Motivational activation: a unifying hypothesis of orexin/hypocretin function.

Mahler SV, Moorman DE, Smith RJ, James MH, Aston-Jones G.

Nat Neurosci. 2014 Oct;17(10):1298-303. doi: 10.1038/nn.3810. Epub 2014 Sep 25. Review.

27.

Exercise reverses the effects of early life stress on orexin cell reactivity in male but not female rats.

James MH, Campbell EJ, Walker FR, Smith DW, Richardson HN, Hodgson DM, Dayas CV.

Front Behav Neurosci. 2014 Jul 23;8:244. doi: 10.3389/fnbeh.2014.00244. eCollection 2014.

28.

Altered formalin-induced pain and Fos induction in the periaqueductal grey of preadolescent rats following neonatal LPS exposure.

Zouikr I, James MH, Campbell EJ, Clifton VL, Beagley KW, Dayas CV, Hodgson DM.

PLoS One. 2014 May 30;9(5):e98382. doi: 10.1371/journal.pone.0098382. eCollection 2014.

29.

Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls.

Yeoh JW, Campbell EJ, James MH, Graham BA, Dayas CV.

Front Neurosci. 2014 Feb 25;8:36. doi: 10.3389/fnins.2014.00036. eCollection 2014. Review.

30.

Artificial urinary sphincter for post-prostatectomy incontinence: a review.

James MH, McCammon KA.

Int J Urol. 2014 Jun;21(6):536-43. doi: 10.1111/iju.12392. Epub 2014 Feb 16. Review.

31.

mTORC1 inhibition in the nucleus accumbens 'protects' against the expression of drug seeking and 'relapse' and is associated with reductions in GluA1 AMPAR and CAMKIIα levels.

James MH, Quinn RK, Ong LK, Levi EM, Charnley JL, Smith DW, Dickson PW, Dayas CV.

Neuropsychopharmacology. 2014 Jun;39(7):1694-702. doi: 10.1038/npp.2014.16. Epub 2014 Jan 28.

32.

Clinical staging: a necessary step in the development of improved animal models of mood disturbance?

Walker FR, James MH, Hickie IB, McGorry PD.

Int J Neuropsychopharmacol. 2014 Mar;17(3):491-5. doi: 10.1017/S1461145713001107. Epub 2013 Oct 16.

PMID:
24128407
33.

The urachal flap: a previously unreported tissue flap in vesicovaginal fistula repair.

James MH, Tisdale BE, Davies TO, McCammon KA.

Female Pelvic Med Reconstr Surg. 2013 May-Jun;19(3):148-51. doi: 10.1097/SPV.0b013e3182830b67.

PMID:
23611932
34.

What about me…? The PVT: a role for the paraventricular thalamus (PVT) in drug-seeking behavior.

James MH, Dayas CV.

Front Behav Neurosci. 2013 Mar 6;7:18. doi: 10.3389/fnbeh.2013.00018. eCollection 2013. No abstract available.

35.

Navigating the road ahead: lessons from a pioneer ACO.

James MH.

Healthc Financ Manage. 2012 Aug;66(8):64-9.

PMID:
22931028
36.

Cocaine potentiates excitatory drive in the perifornical/lateral hypothalamus.

Yeoh JW, James MH, Jobling P, Bains JS, Graham BA, Dayas CV.

J Physiol. 2012 Aug 15;590(16):3677-89. doi: 10.1113/jphysiol.2012.230268. Epub 2012 May 28.

37.

Propensity to 'relapse' following exposure to cocaine cues is associated with the recruitment of specific thalamic and epithalamic nuclei.

James MH, Charnley JL, Flynn JR, Smith DW, Dayas CV.

Neuroscience. 2011 Dec 29;199:235-42. doi: 10.1016/j.neuroscience.2011.09.047. Epub 2011 Sep 28.

PMID:
21985936
38.

Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking.

James MH, Charnley JL, Levi EM, Jones E, Yeoh JW, Smith DW, Dayas CV.

Int J Neuropsychopharmacol. 2011 Jun;14(5):684-90. doi: 10.1017/S1461145711000423. Epub 2011 Mar 29.

PMID:
21447232
39.

Cocaine- and amphetamine-regulated transcript (CART) signaling within the paraventricular thalamus modulates cocaine-seeking behaviour.

James MH, Charnley JL, Jones E, Levi EM, Yeoh JW, Flynn JR, Smith DW, Dayas CV.

PLoS One. 2010 Sep 23;5(9):e12980. doi: 10.1371/journal.pone.0012980.

40.

Preventing airborne infection with an intranasal cellulose powder formulation (Nasaleze travel).

Hiltunen R, Josling PD, James MH.

Adv Ther. 2007 Sep-Oct;24(5):1146-53.

PMID:
18029341
41.
42.

Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma.

Ind PW, Dal Negro R, Colman NC, Fletcher CP, Browning D, James MH.

Respir Med. 2003 May;97(5):555-62.

44.

Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences.

Ferrari MD, James MH, Bates D, Pilgrim A, Ashford E, Anderson BA, Nappi G.

Cephalalgia. 1994 Oct;14(5):330-8.

PMID:
7828190
45.

Stress induces an increased hexose uptake in cultured cells.

Warren AP, James MH, Menzies DE, Widnell CC, Whitaker-Dowling PA, Pasternak CA.

J Cell Physiol. 1986 Sep;128(3):383-8.

PMID:
3018000
46.

Changes in excitability induced by herpes simplex viruses in rat dorsal root ganglion neurons.

Mayer ML, James MH, Russell RJ, Kelly JS, Pasternak CA.

J Neurosci. 1986 Feb;6(2):391-402.

47.

Increased sugar transport in BHK cells infected with Semliki Forest virus or with herpes simplex virus.

Gray MA, James MH, Booth JC, Pasternak CA.

Arch Virol. 1986;87(1-2):37-48.

PMID:
3002302
48.

Spontaneous electrical activity induced by herpes virus infection in rat sensory neuron cultures.

Mayer ML, James MH, Russell RJ, Kelly JS, Wise JC, Pasternak CA.

Brain Res. 1985 Aug 26;341(2):360-4.

PMID:
4041799
49.

Social support and post-burn adjustment.

Davidson TN, Bowden ML, Tholen D, James MH, Feller I.

Arch Phys Med Rehabil. 1981 Jun;62(6):274-8.

PMID:
7235921
50.

Self-esteem of severely burned patients.

Bowden ML, Feller I, Tholen D, Davidson TN, James MH.

Arch Phys Med Rehabil. 1980 Oct;61(10):449-52.

PMID:
7425816

Supplemental Content

Loading ...
Support Center